What is FOLFOX and when is it used for Ovarian Cancer

Ovarian CancerMay 15, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

FOLFOX for Ovarian Cancer: What You Need to Know

What is FOLFOX?

FOLFOX is a chemotherapy combination made up of four drugs:

  • FOL = Leucovorin (also called folinic acid)
  • F = Fluorouracil (5-FU)
  • IRI = Irinotecan
  • OX = Oxaliplatin

These drugs work together to attack cancer cells in different ways. The combination is given through IV (intravenous) infusions, typically over several days in a repeating cycle.

Use in Ovarian Cancer

Important context: FOLFOX is not a standard first-line treatment for epithelial ovarian cancer. According to the NCCN Guidelines for Ovarian Cancer, the typical first-line chemotherapy for advanced ovarian cancer uses paclitaxel and carboplatin (platinum-based therapy), often combined with bevacizumab (an anti-angiogenesis drug).

However, FOLFOX may be considered in specific situations:

When FOLFOX Might Be Used:

  1. Platinum-resistant or platinum-refractory disease - When ovarian cancer has progressed despite platinum-based chemotherapy or grows back quickly after treatment
  2. Recurrent ovarian cancer - For patients whose cancer has returned after initial treatment
  3. Specific histologic subtypes - Particularly for mucinous ovarian carcinoma, where FOLFOX-type regimens (similar to colorectal cancer protocols) may be more appropriate than standard ovarian cancer chemotherapy

According to NCCN Guidelines, for patients with mucinous ovarian cancer, gastrointestinal-type chemotherapy approaches may be used, which can include FOLFOX-based regimens.

Important Considerations

Oxaliplatin side effects: One significant concern with FOLFOX is peripheral neuropathy (nerve damage in hands and feet). According to NCCN Guidelines, oxaliplatin should typically be discontinued after 3 months of therapy or sooner if unacceptable nerve damage develops, while other drugs in the regimen continue.

Questions to Ask Your Oncologist

If FOLFOX is being considered for your care:

  1. Why is FOLFOX being recommended for my specific situation? (What makes it the best choice for my cancer type and stage?)
  2. What are the expected side effects, and how will they be managed?
  3. How long will I receive FOLFOX, and what happens after that?
  4. Are there other treatment options I should consider?
  5. How will my response to treatment be monitored?

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: